Home
Search:
print
SFB 684/CRC 684 Molekular Mechanisms of Normal and Malignant Hematopoesis
SFB 684/CRC 684 Molekular Mechanisms of Normal and Malignant Hematopoesis
It is the aim of this collaborative research center (CRC) to dissect the molecular pathways and mechanisms that govern normal and malignant hematopoiesis. This will be accomplished by a close interaction between investigations focusing on single molecules or defined molecular pathways and analyses addressing the complexity of the disease and the physiological differentiation processes by using sophisticated model systems and patient material. The basis for this challenging approach is provided through the cooperation between well established basic researchers, junior group leaders and physician scientists and is supported by the access to patient material from the controlled clinical trials of the German AML Cooperative Group. [more]

Announcements

21.06.2012 at 18:00 

Seminars & Events
Lars Bullinger, Universitätsklinikum Ulm
"Omics in acute myeloid leukemia - integrative analyses open new avenues"
[more]

31.05.2012 at 18:00 

Seminars & Events
Michael Heuser, MH-Hannover
"Myeloid differentiation as a therapeutic target in AML"
[more]

19.04.2012 at 17:00 

Seminars & Events
Stefan Woehrer, Medical University of Vienna, Austria
"New Insights into the Self-Renewal and Differentiation Potential of Mouse Hematopoietic Stem Cells"
[more]

Imprint - Privacy Disclaimer - Contact